| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $2K | — | -95.7% |
| Operating Income | -$737K | — | +92.3% |
| Interest Expense | $39K | — | -31.6% |
| Net Income | -$781K | — | +91.9% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $80K | +45.5% | -85.9% |
| Total Assets | $80K | +45.5% | -85.9% |
| Current Liabilities | $5.9M | -1.1% | +19.4% |
| Total Liabilities | $5.9M | -1.1% | +19.4% |
| Stockholders' Equity | -$5.8M | +1.5% | -33.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$468K | — | +59.5% |
| Financing Cash Flow | $495K | — | -67.7% |